Christopher A. Kroeger Insider Trades & Stock Holdings

Chief Executive Officer · MapLight Therapeutics, Inc. · Latest filing Oct 15, 2026

Christopher A. Kroeger, Chief Executive Officer at MapLight Therapeutics, Inc. has 1 Form 4 trade on file since Oct 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($595.42K), net -$595.42K. Latest filing: disposed of 73.69K shares of $MPLT on Oct 15, 2026 at $8.08.

Trades on file

1

Open-market bought

$0

Open-market sold

$595.42K

Net open-market

-$595.42K

Shares held ($MPLT)

1.20M

Latest filing

Oct 15, 2026

Shares held by Christopher A. Kroeger

• $MPLT1.20M sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Christopher A. Kroeger

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 15, 2026	$MPLT	Sell (Open-market sale)	73.69K	$8.08	$595.42K	1.20M	-5.80%				Chief Executive Officer	SEC	—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Christopher A. Kroeger traded

• $MPLT

Frequently asked questions

Has Christopher A. Kroeger been buying or selling stock?

Christopher A. Kroeger has 0 open-market purchases and 1 open-market sale on file, net -$595.42K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Christopher A. Kroeger's latest insider trade?

disposed of 73.69K shares of $MPLT on Oct 15, 2026 at $8.08.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.